Qrons Inc QRON
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.14
- Bid/Ask
- $0.02 / $0.07
- Shares Outstanding
- 17.91M
- Market Cap
- $198,856.49
- Volume/Avg
- 100 / 14,734
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Qrons Inc. is a biotechnology company, dedicated to developing biotech products, treatments, and technologies to combat neuronal and infectious diseases with a focus on antibiotic-resistant bacteria, which is becoming the prominent and rapidly growing world-wide cause of illness and death. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The company has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM for treating concussions and other diffused axonal injuries.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- https://www.firstpersongroup.com
Valuation
|
Metric
|
QRON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
QRON
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | 0.06 |
Quick Ratio
QRON
Profitability
|
Metric
|
QRON
|
|---|---|
Return on Assets (Normalized) | −9,119.66% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
QRON
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|z?<D^#d | LOCK|F>DRZ | $131B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|>#wg@% | LOCK|%@Cx | $80B | |||
| argenx SE ADR
ARGX
| LOCK|y?Wycy | LOCK|>^Y | $62B | |||
| Moderna Inc
MRNA
| LOCK|s%%YkY | LOCK|qC | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|g%n<Hk$ | LOCK|sB | $40B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|L^pM?W | LOCK|j<@s | $33B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|%mKh!?? | LOCK|Q$R>? | $26B | |||
| Incyte Corp
INCY
| LOCK|h<kRg?? | LOCK|>R | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|&<!pP$N | LOCK|GD | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Chk&g& | LOCK|?^ | $16B |
United States